On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and ...
This guide is designed to help leaders prepare for and structure discussions on strategies to mitigate challenges to healthcare capacity during the 2023 fall and winter respiratory illness season.
If there’s anyone who has spent their career preparing for a global pandemic, it’s Anne Schuchat, MD. Currently, she serves as the principal deputy director of the Centers for Disease Control and ...
On this bonus episode of Public Health Review, we chat with Stanley Campbell, CEO and CTO EagleForce. Campbell is an expert in artificial intelligence who knows how to leverage data in the fight ...
On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
As we anticipate the likely approval of COVID-19 vaccination for children, our nation faces the final step to bring the COVID-19 pandemic under control. If approved for children ages 5-11, the ...
On this bonus episode of Public Health Review, we discuss how a business or government can create vaccine credentials that are more sophisticated than the paper cards from CDC, but that also protect ...
Our experts on this episode also discuss that while there have been perceived challenges in the initial COVID-19 vaccine rollout, the overall effort of getting vaccines into the arms of a virus that ...
On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
Nirav Shah, Director of Maine Center for Disease Control and Prevention, and Joe Smyser, CEO of Public Good Projects, discuss countering COVID-19 vaccine misinformation.